We are live on
!
Find out more
Korro Bio
KRRO
KRRO
Fund managers haven’t disclosed any holdings of KRRO yet.
KRRO Hedge Fund Activity: Q1 2026 in Review
99 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q1 2026, worth a combined $145M — up 139% from $60.6M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new KRRO positions and 15 closed out — a net gain of 18 holders — while 33 added to existing stakes and 20 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $11.4M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $2.17M sold.
- 99 institutional investors held Korro Bio (KRRO) as of Q1 2026, up from 83 in Q4 2025.
- Funds reported $145M of Korro Bio stock for Q1 2026, up 139% quarter-over-quarter.
- 33 funds opened new Korro Bio positions in Q1 2026 and 15 closed out, a net change of +18 holders.
- The largest Korro Bio buyer in Q1 2026 was Balyasny Asset Management, an estimated $11.4M added.
- The largest Korro Bio seller in Q1 2026 was Susquehanna International Group, an estimated $2.17M sold.
Based on aggregated 13F filings for Q1 2026.